Redeye updates on Invisio following the company’s Q1-results which came in much stronger than expected and the company reiterates a positive outlook for 2023. We raise our EBITDA estimates with around 24% for 2023E and 11-13% for 2024-25E while our base case is increased to SEK260 (SEK230).

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases